Nasdaq Stockholm AB: The observation status Redwood Pharma A

On March 21, 2024, the shares in Redwood Pharma AB (the "Company") were given
observation status with reference to material adverse uncertainty in respect of
the issuer's financial position. Today, on

Related Keywords

Stockholm , Sweden , , Redwood Pharma , Nasdaq First North Growth , Nasdaq First North Growth Market , Nasdaq Stockholm , Ihr Portfolio ,